$CXT Balance Sheet | Understand Stock

$CXT

$58.29 -$0.15 (0.26%) Close

$CXT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated and condensed balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Current insurance receivable - asbestos
Accounts receivable, net of allowance for credit losses of $11.2 as of June 30, 2026 and $8.9 as of December 31, 2025
U.S. and foreign taxes on income
Inventories, net
Finished goods
Finished parts and subassemblies
Work in process
Raw materials
Inventories, net:
Other current assets
Current assets held for sale
Total current assets

Property, plant and equipment, net
Cost
Less: accumulated depreciation
Property, plant and equipment, net
Insurance receivable - asbestos

Long-term deferred tax assets
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures
Intangible assets, net
Goodwill
Other assets
Long-term assets held for sale
Total assets

Liabilities and equity
Current liabilities:
Short-term borrowings
Accounts payable
Current asbestos liability
Contract liabilities
Accrued liabilities
U.S. and foreign taxes on income
Current liabilities held for sale
Total current liabilities

Long-term debt
Accrued pension and postretirement benefits
Long-term deferred tax liability
Long-term asbestos liability
Other liabilities
Long-term liabilities held for sale
Total liabilities
Redeemable Noncontrolling Interest, Equity, Carrying Amount
Equity:
Preferred shares, par value $0.01; 5,000,000 shares authorized
Common shares, par value $1.00; 200,000,000 shares authorized
Capital surplus
Retained earnings
Crane net investment
Accumulated other comprehensive loss
Treasury stock
Total shareholders’ equity
Nonredeemable noncontrolling interests
Total equity
Total liabilities, redeemable noncontrolling interests, and equity

Share data:
Common shares issued (in shares)
Less: Common shares held in treasury (in shares)
Common shares outstanding (in shares)
Preferred shares, authorized (in shares)
Preferred shares, par value (in dollars per share)
Common shares, authorized (in shares)
Common shares, par value (in dollars per share)

Comments